Within the department the Valk group runs the molecular diagnostic unit that routinely examines relevant clinically biomarkers in various hematologic malignancies, i.e., AML, acute lymphoblastic leukemia, chronic myeloid leukemia, myeloproliferative disorders and others. The laboratory is accredited by the ISO15189. The molecular diagnostic unit at the department of Hematology acts as central reference laboratories for all participating centers in the international and multicenter HOVON-SAKK clinical AML trials.

Our team